Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Nigel Iskander
AddedFeb 16, 2024
UpdatedMay 1, 2026
Nigel Iskander

Nigel Iskander

Co-Founder, Cambridge Nutraceuticals

Nigel Iskander's Career

Cambridge Nutraceuticals
Cambridge Nutraceuticals

Boston, MA, US

Co-Founder
Cambridge Nutraceuticals
Cambridge Nutraceuticals
Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Nigel Iskander's Career

Cambridge Nutraceuticals
Cambridge Nutraceuticals
Seed$4.6M752010Boston, MA, US
Co-Founder

Similar to Cambridge Nutraceuticals

Cambridge NutraceuticalsCambridge NutraceuticalsSupplementsest. 2010Cambridge Nutraceuticalsest. 2010

Cambridge Nutraceuticals, a supplement company, develops bioavailable, clinically-proven products, supported by a high-profile medical board.

Seed · $2.9M1
Cambridge DevicesCambridge DevicesCambridge, MA, USMedical Devicesest. 2004Cambridge DevicesCambridge, MA, US · est. 2004

Cambridge Devices: Innovating real-time pathology solutions.

Seed · $2.5M5
Sevo NutraceuticalsSevo NutraceuticalsWaltham, MA, USNutraceuticalsest. 2012Sevo NutraceuticalsWaltham, MA, US · est. 2012

Sevo Nutraceuticals, a medical company, develops science-backed nutraceuticals to improve lives.

Angel · $300k6
Cambridge Therapeutic TechnologiesCambridge Therapeutic TechnologiesTeaneck, NJ, USHealthcare, Pharmaceuticalsest. 2011Cambridge Therapeutic TechnologiesTeaneck, NJ, US · est. 2011

Cambridge Therapeutic Technologies: Innovating healthcare through specialized pharmaceutical solutions since 2011.

Series A · $6M6
Cambridge Nutraceuticals
Cambridge Nutraceuticals
Seed$2.9M12010
Co-Founder

Leadership at Cambridge Nutraceuticals

Eddie PowellEddie PowellCo-Founder
Adam CleevelyAdam CleevelyCEO

Similar to Cambridge Nutraceuticals

Cambridge NutraceuticalsCambridge NutraceuticalsBoston, MA, USHealthcare Productsest. 2010Cambridge NutraceuticalsBoston, MA, US · est. 2010

CamNutra, a medical organization, develops and markets clinically-proven natural healthcare products to combat chronic health conditions.

Seed · $4.6M75
BodyBioBodyBioMillville, NJ, USSupplementsest. 1999BodyBioMillville, NJ, US · est. 1999

BodyBio: A leading nutritional supplement company dedicated to advancing cellular health.

Seed · $675k34
BrainceuticalsBrainceuticalsDallas, TX, USSupplementsest. 2009BrainceuticalsDallas, TX, US · est. 2009

Brainceuticals, LLC: A Dallas-based brain health supplement manufacturer since 2009.

Seed · $249.5k6
Columbia NutritionalColumbia NutritionalVancouver, WA, USManufacturing, Supplementsest. 1998Columbia NutritionalVancouver, WA, US · est. 1998

Columbia Nutritional: Global provider of premium dietary supplement manufacturing services.

Seed · $2.2M125

People Similar to Nigel Iskander

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · KakaoFilipp ChebotarevFilipp ChebotarevBoard Member · FoodstirsKenneth SalasKenneth SalasCo-Founder · Camino FinancialMichael RyanMichael RyanCo-Founder · Camus EnergyGeorge ClarkGeorge ClarkCo-Founder · Allpur NutritionAnton RosandicAnton RosandicCo-Founder · brokkrrMirza MufticMirza MufticCo-Founder · Vyoocam